发明名称 ブラジキニンB1アンタゴニストとしての化合物
摘要 The present invention relates to the compounds of general formula I wherein n, R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11 and X are defined as described hereinafter, the enantiomers, the diastereomers, the mixtures and the salts thereof, particularly the physiologically acceptable salts thereof with organic or inorganic acids or bases, which have valuable properties, the preparation thereof, the medicaments containing the pharmacologically effective compounds, the preparation thereof and the use thereof.
申请公布号 JP5629274(B2) 申请公布日期 2014.11.19
申请号 JP20110551480 申请日期 2010.02.23
申请人 发明人
分类号 C07C237/24;A61K31/165;A61K31/166;A61K31/17;A61K31/341;A61K31/351;A61K31/4015;A61K31/4025;A61K31/4155;A61K31/4164;A61K31/4192;A61K31/42;A61K31/422;A61K31/4245;A61K31/426;A61K31/427;A61K31/437;A61K31/44;A61K31/4402;A61K31/443;A61K31/4439;A61K31/444;A61K31/445;A61K31/4525;A61K31/455;A61K31/497;A61K31/501;A61K31/505;A61K31/506;A61K38/00;A61P17/00;A61P19/02;A61P25/04;A61P29/00;A61P43/00;C07D207/28;C07D211/62;C07D213/74;C07D213/81;C07D213/82;C07D233/90;C07D239/28;C07D261/18;C07D271/10;C07D277/20;C07D277/32;C07D307/24;C07D307/68;C07D401/12;C07D405/12;C07D407/12;C07D407/14;C07D409/14;C07D413/12;C07D417/12;C07D471/04 主分类号 C07C237/24
代理机构 代理人
主权项
地址